Study S001228

Efficacy and Safety Of Different Hypoglycemic Regimens Compared With Premixed Insulin In Patients With Type 2 Diabetes Receiving Short-term Intensive Insulin Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05545800
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: SINGLE
Status: UNKNOWN
Enrollment: 78
Start: 2022-09-01
Primary completion: 2024-06-01
Lead sponsor: Xiangya Hospital of Central South University
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:metformin+empagliflozin+insulin glargine; DRUG:IDegLira; DRUG:premixed insulin analogues
Results posted: FALSE

Registered primary outcomes

Mean Change From Baseline in HbA1c [Month 0 to 3]
Percentage of patients achieving HbA1c <7% [Month 0 to 3]
Amplitude of glycemic excursions [Month 0 to 3]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.